Literature DB >> 19122289

Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3).

Marie Nagai1, Takahiro Fukamachi, Masayuki Tsujimoto, Kenichiro Ogura, Akira Hiratsuka, Hisakazu Ohtani, Satoko Hori, Yasufumi Sawada.   

Abstract

Sulfotransferase 1A3 (SULT1A3) is a phase II detoxifying enzyme of xenobiotics predominantly expressed in the intestinal epithelium. Recent increase in the use of herbal extracts as dietary supplements may lead to an increase in the possibility of dietary supplement-drug interactions. The purpose of the present study was to investigate the effects of 18 herbal extracts on SULT1A3 activity and the possibility of interaction between medicinal drugs and herbal extracts. We examined the inhibitory potencies of 18 herbal extracts on the sulfation of dopamine, a typical substrate of SULT1A3, and ritodrine, a beta(2) stimulant, by human recombinant SULT1A3. The sulfation of dopamine was inhibited by extracts of banaba, green tea, Rafuma, grape seed, peanut seed coat, gingko biloba leaf, St. John's wort, gymnema and milkthistle. The IC(50) values of these herbal extracts were lower than the putative gastrointestinal concentration when the recommended dose was ingested. On the other hand, chlorella extract and rutin showed no inhibitory effects and wheat, mulberry and siberian ginseng had IC(50) values exceedingly higher than the putative gastrointestinal concentration. The inhibitory profiles of herbal extracts for the sulfation of ritodrine were comparable to those for the sulfation of dopamine. In conclusion, the extracts of herbs such as banaba and green tea potently inhibited SULT1A3 activity. These extracts may increase the bioavailability of drugs whose bioavailabilities were limited by the function of SULT1A3 on the intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19122289     DOI: 10.1248/bpb.32.105

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Five Supplements and Multiple Psychotic Symptoms: A Case Report.

Authors:  Michelle K Wong; Ayeh Darvishzadeh; Neal A Maler; Robert G Bota
Journal:  Prim Care Companion CNS Disord       Date:  2016-01-14

2.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

3.  A six-month supplementation of mulberry, korean red ginseng, and banaba decreases biomarkers of systemic low-grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes.

Authors:  H-J Kim; K-H Yoon; M-J Kang; H-W Yim; K-S Lee; V Vuksan; M-K Sung
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-28       Impact factor: 2.629

4.  Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen.

Authors:  Yanli Zhao; Jerold S Harmatz; Carol R Epstein; Yukako Nakagawa; Chie Kurosaki; Tetsuro Nakamura; Takumi Kadota; Dennis Giesing; Michael H Court; David J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  2015-06-08       Impact factor: 4.335

Review 5.  Key factors which concur to the correct therapeutic evaluation of herbal products in free radical-induced diseases.

Authors:  Cesare Mancuso
Journal:  Front Pharmacol       Date:  2015-04-22       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.